Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Frontiers in PharmacologyOpen Access

Opportunities and challenges in the treatment of IgA nephropathy

View Full Paper
Ask AI
Bookmark
Share

Authors

YYYang YangShanghai Medical College of Fudan UniversityGXGaosi XuNanchang University

Discussion

Loading...

Member takes

Implication

Review highlights emerging anti-inflammatory strategies and potential targeted therapies for IgAN.

Key Points

  • Emerging treatment approaches for IgAN show potential in achieving individualized therapies.
  • Current therapies focus on anti-inflammatory methods and optimizing treatment regimens in patients.
  • Investigational therapies include complement inhibitors and combined medications targeting specific pathways.
  • IgAN requires lifelong management with varying treatment strategies across different patient populations.

Cite This Study

Yang et al. (2025) studied this question.

synapsesocial.com/papers/68c1a13a54b1d3bfb60dc93ahttps://doi.org/10.3389/fphar.2025.1559593
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Recent Advances in the Management of IgA Nephropathy: From Supportive Care to Targeted Therapies2026
  2. 2Evolving therapeutic landscape of immunoglobulin A nephropathy: targeted immune pathways and novel therapies2026 · 2 citations
  3. 3New Horizons in IgA Nephropathy: Approach to Current and Emerging Therapies2026
  4. 4Targeted therapeutic options based on the pathogenesis of IgA nephropathy2025 · 1 citations
  5. 5IgA nephropathy: a paradigm shift in treatment strategies2025 · 5 citations